Ultra-thin cryoneedles prove safety in renal tumours:
This article was originally published in Clinica
Executive Summary
Galil Medical says a study has backed the use of its ultra-thin cryoablation needles for treating renal tumours. The needles, which are designed to avoid harming healthy tissue surrounding the tumour, minimised patient blood loss and caused no complications either during or after the operation, said the study. Notably, they compared favourably with the performance associated with large diameter cyroneedles, which have led to significant renal bleeding, said the Yokneam, Israel-based firm. This third generation cyroneedle technology is safe and effective in ablating renal tumours, concluded the study in the journal Urology (January).